Target intelligence / Profile preview

Zinc finger protein 260 pseudogene

Molecular classification
Other
01

Overview

Zinc finger protein 260 pseudogene (ENSG00000255057) is annotated in Ensembl as a pseudogene, meaning it is a genomic DNA sequence similar to but nonfunctional relative to a protein-coding gene—in this case, similar to the active ZNF260 ("Zinc finger protein 260"). Pseudogenes generally do not encode functional proteins due to mutations or deletions; as such, this entity is not a therapeutic target, is not a receptor, enzyme, or transcription factor, and is absent from curated drug, biomarker, or disease association databases. The active form of zinc finger protein 260 (ZNF260) functions as a transcription factor and cardiac regulator[1][5], but the pseudogene itself has no established function, clinical role, or druggability[1][5]. Notes on correctness: This target is flagged as "incorrect" for drug targeting purposes because it is a pseudogene, not an active molecular target. Pseudogenes are not considered functional drug targets and usually lack protein expression, interaction, or disease roles relevant for therapeutic intervention.

02

Disease associations

Other

Beyond the preview

Go deeper on Zinc finger protein 260 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 260 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call